To determine the differential profiles of sphingomyelin, sphingoid base, sphingoid base-1-phosphate, and ceramide and their quantitative differences between trabecular meshwork (TM) derived from normotensive and hypertensive intraocular pressure states of DBA/2J mice.
Methods:
Normotensive and hypertensive state TM were collected from mice and analyzed. Lipid extraction was performed using the Bligh and Dyer method, and the protein concentrations were determined using the Bradford method. The lipids were identified and quantified using appropriate standards with a TSQ Quantum Access Max triple quadrupole mass spectrometer applying class-specific lipid identification settings.
Results:
The comparative profiles of sphingomyelin, sphingoid base, sphingoid base-1-phosphate, and ceramide between normotensive and hypertensive TM showed several species unique to a phase and as well common between states.
Conclusion:
The presence or absence of several sphingolipids and ceramides in the normotensive or hypertensive states may contribute to better understanding of the glaucomas.
CalkinsD.J.Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog. Retin. Eye. Res., 31:702–719, 2012.
3.
MorrisonJ.C., and AcottT.S. In: MorrisonJ.C., and PollackI.P., eds. Anatomy and physiology of aqueous humor outflow. Glaucoma Science and Practice. 34–41. New York: Thieme Medical Publishers, Inc.; 2003.
4.
FautschM.P., and JohnsonD.H.Aqueous humor outflow: what do we know? Where will it lead us?. Invest. Ophthalmol. Vis. Sci., 47:4181–4187, 2006.
5.
PiomelliD., AstaritaG., and RapakaR.A neuroscientist's guide to lipidomics. Nat. Rev. Neurosci., 8:743–754, 2007.
6.
WanZ., WoodwardD.F., and StamerW.D.Endogenous Bioactive Lipids and the Regulation of Conventional Outflow Facility. Expert. Rev. Ophthalmol., 3:457–470, 2008.
7.
Terelak-BorysB., and LiberekI.[Neuro-hormonal regulation of aqueous humor dynamics as the basis of glaucoma pharmacotherapy. Part II—Aqueous humor outflow]. Klin. Oczna., 109:64–67, 2007.
8.
AmbacheN.Irin, a smooth-muscle contracting substance present in rabbit iris. J. Physiol., 129:65–6P, 1955.
9.
TorisC.B., GabeltB.T., and KaufmanP.L.Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Surv. Ophthalmol., 53Suppl1:S107–S120, 2008.
10.
LibbyR.T., AndersonM.G., PangI.H., et al.Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis. Neurosci., 22:637–648, 2005.
11.
BhattacharyaS.K., RockwoodE.J., SmithS.D., et al.Proteomics reveal Cochlin deposits associated with glaucomatous trabecular meshwork. J. Biol. Chem., 280:6080–6084, 2005.
12.
GoelM., SienkiewiczA.E., PiccianiR., et al.Cochlin, intraocular pressure regulation and mechanosensing. PLoS. One., 7:e34309, 2012.
13.
JohnS.W., HagamanJ.R., MacTaggartT.E., PengL., and SmithesO.Intraocular pressure in inbred mouse strains. Invest. Ophthalmol. Vis. Sci., 38:249–253, 1997.
14.
JohnS.W., SmithR.S., SavinovaO.V., et al.Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest. Ophthalmol. Vis. Sci., 39:951–962, 1998.
15.
AribindiK., GuerraY., LeeR.K., and BhattacharyaS.K.Comparative phospholipid profiles of control and glaucomatous human trabecular meshwork. Invest. Ophthalmol. Vis. Sci., 54:3037–3044, 2013.
16.
BlighE.G., and DyerW.J.A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol., 37:911–917, 1959.
17.
BradfordM.M.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72:248–254, 1976.
18.
CraneA.M., HuaH.U., CogginA.D., et al.Mass spectrometric analyses of phosphatidylcholines in alkali-exposed corneal tissue. Invest. Ophthalmol. Vis. Sci., 53:7122–7130, 2012.
19.
BhattacharyaS.K.Recent advances in shotgun lipidomics and their implication for vision research and ophthalmology. Curr. Eye. Res., 38:417–427, 2013.
20.
YangK., ChengH., GrossR.W., and HanX.Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics. Anal. Chem., 81:4356–4368, 2009.
21.
HanX., YangK., and GrossR.W.Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass. Spectrom. Rev., 2011.
22.
HanX.Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease. Biochim. Biophys. Acta., 1801:774–783, 2010.
23.
PluskalT., CastilloS., Villar-BrionesA., and OresicM.MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC. Bioinform., 11:395, 2010.
24.
AribindiK., GuerraY., PiquerasM.C., et al.Cholesterol and glycosphingolipids of human trabecular meshwork and aqueous humor: comparative profiles from control and glaucomatous donors. Curr. Eye. Res., 38:1017–1026, 2013.
25.
BenjaminA., KashemM., CohenC., et al.Proteomics of the nucleus ovoidalis and field L brain regions of zebra finch. J. Proteome. Res., 7:2121–2132, 2008.
26.
JohnS.W., AndersonM.G., and SmithR.S.Mouse genetics: a tool to help unlock the mechanisms of glaucoma. J. Glaucoma., 8:400–412, 1999.
27.
GordonM.O., BeiserJ.A., BrandtJ.D., et al.The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch. Ophthalmol., 120:714–720; discussion 829–830, 2002.
28.
MerrillA.H.Jr., WangM.D., ParkM., and SullardsM.C.(Glyco)sphingolipidology: an amazing challenge and opportunity for systems biology. Trends. Biochem. Sci., 32:457–468, 2007.
29.
HaynesC.A., AllegoodJ.C., ParkH., and SullardsM.C.Sphingolipidomics: methods for the comprehensive analysis of sphingolipids. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 877:2696–2708, 2009.
30.
ZeidanY.H., and HannunY.A.The acid sphingomyelinase/ceramide pathway: biomedical significance and mechanisms of regulation. Curr. Mol. Med., 10:454–466, 2010.
31.
BollingerK.E., CrabbJ.S., YuanX., et al.Proteomic similarities in steroid responsiveness in normal and glaucomatous trabecular meshwork cells. Mol. Vis., 18:2001–2011, 2012.
32.
LiuX., ChengJ.C., TurnerL.S., et al.Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy. Expert. Opin. Ther. Targets., 13:1449–1458, 2009.
33.
HorresC.R., and HannunY.A.The roles of neutral sphingomyelinases in neurological pathologies. Neurochem. Res., 37:1137–1149, 2012.
34.
van MeerG.Dynamic transbilayer lipid asymmetry. Cold. Spring Harb. Perspect. Biol., 3, 2011.
35.
vanMeer, G., and HoetzlS.Sphingolipid topology and the dynamic organization and function of membrane proteins. FEBS. Lett., 584:1800–1805, 2010.
36.
MettuP.S., DengP.F., MisraU.K., et al.Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility. Invest. Ophthalmol. Vis. Sci., 45:2263–2271, 2004.
37.
SumidaG.M., and StamerW.D.Sphingosine-1-phosphate enhancement of cortical actomyosin organization in cultured human Schlemm's canal endothelial cell monolayers. Invest. Ophthalmol. Vis. Sci., 51:6633–6638, 2010.
38.
SumidaG.M., and StamerW.D.S1P(2) receptor regulation of sphingosine-1-phosphate effects on conventional outflow physiology. Am. J. Physiol. Cell Physiol., 300:C1164–C1171, 2011.
39.
DeeleyJ.M., MitchellT.W., WeiX., et al.Human lens lipids differ markedly from those of commonly used experimental animals. Biochim. Biophys. Acta., 1781:288–298, 2008.
40.
ValsecchiM., MauriL., CasellatoR., et al.Ceramide and sphingomyelin species of fibroblasts and neurons in culture. J. Lipid. Res., 48:417–424, 2007.
41.
ZhaiX., LiX.M., MomsenM.M., BrockmanH.L., and BrownR.E.Lactosylceramide: lateral interactions with cholesterol. Biophys. J., 91:2490–2500, 2006.
42.
LiX.M., MomsenM.M., BrockmanH.L., and BrownR.E.Sterol structure and sphingomyelin acyl chain length modulate lateral packing elasticity and detergent solubility in model membranes. Biophys. J., 85:3788–3801, 2003.
43.
FananiM.L., HartelS., OliveiraR.G., and MaggioB.Bidirectional control of sphingomyelinase activity and surface topography in lipid monolayers. Biophys. J., 83:3416–3424, 2002.
44.
FananiM.L., and MaggioB.Surface pressure-dependent cross-modulation of sphingomyelinase and phospholipase A2 in monolayers. Lipids., 33:1079–1087, 1998.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
